谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Two Years Rituximab Maintenance Vs. Observation after First Line Treatment with Bendamustine Plus Rituximab (B-R) in Patients with Marginal Zone Lymphoma (MZL): Results of a Prospective, Randomized, Multicenter Phase 2 Study (the StiL NHL7-2008 MAINTAIN Trial).

M. Rummel,M. Koenigsmann,K. U. Chow,W. Knauf,C. A. Lerchenmueller,C. Losem,M. Goerner,B. Hertenstein,T. Decker,A. Ganser,T. Gaska, M. Heike,E. Lange, R. Weide,W. Willenbacher,A. Burchardt,F. Kauff,J. Barth,A. Hinke,R. Greil

Journal of Clinical Oncology（2018）

引用 16|浏览95
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要